%0 Journal Article
%T Exhaled nitric oxide and urinary EPX levels in infants: a pilot study
%A Fredrik Carlstedt
%A Dagmara Lazowska
%A Carl-Gustaf Bornehag
%A Anna-Carin Olin
%A Mikael Hasselgren
%J Clinical and Molecular Allergy
%D 2011
%I BioMed Central
%R 10.1186/1476-7961-9-8
%X To investigate the feasibility of measuring FeNO and uEPX in infants and their mothers and to determine if any relations between these two variables and environmental factors can be seen in a small sample size. This was conducted as a pilot study for the ongoing Swedish Environmental Longitudinal Mother and child Asthma and allergy study (SELMA).Consecutive infants between two and six months old and their mothers at children's health care centres were invited, and 110 mother-infant pairs participated. FeNO and uEPX were analysed in both mothers and infants. FeNO was analyzed in the mothers online by the use of the handheld Niox Mino device and in the infants offline from exhaled air sampled during tidal breathing. A 33-question multiple-choice questionnaire that dealt with symptoms of allergic disease, heredity, and housing characteristics was used.FeNO levels were reduced in infants with a history of upper respiratory symptoms during the previous two weeks (p < 0.002). There was a trend towards higher FeNO levels in infants with windowpane condensation in the home (p < 0.05). There was no association between uEPX in the infants and the other studied variables.The use of uEPX as a marker of early inflammation was not supported. FeNO levels in infants were associated to windowpane condensation. Measuring FeNO by the present method may be an interesting way of evaluating early airway inflammation. In a major population study, however, the method is difficult to use, for practical reasons.Asthma and allergic diseases in children are important public health problems, but they are not fully understood from an aetiological point of view. Allergic diseases usually start in early childhood with food allergies and atopic dermatitis, followed by asthma and rhinitis. These conditions are usually diagnosed in a clinical setting when they are manifest. However, there is a strong need for early and objective markers of preclinical disease, as eosinophilic inflammation, both in cl
%K Nitric Oxide
%K Eosinophil Granule Proteins
%K Infant
%K Housing
%K Allergy and Immunology
%U http://www.clinicalmolecularallergy.com/content/9/1/8